Biogen Idec Announces Webcast of Analyst Discussion at ASH.CAMBRIDGE, Mass. and SAN DIEGO -- Biogen Idec Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BIIB) announced today that its analyst discussion of abstracts related to Rituxan(R) (rituximab) and Zevalin(R) (Ibritumomab tiuxetan) at the American Society of Hematology (ASH) will be webcast live on Saturday, December 4, 2004. The live webcast begins at 11:00 am (EST EST electroshock therapy. EST abbr. electroshock therapy ) / 8:00 am (PST PST Paroxysmal supraventricular tachycardia, see there ) and is accessible through Biogen Idec's website, www.biogenidec.com. About Biogen Idec Biogen Idec creates new standards of care Standards of care are medical or psychological treatment guidelines, and can be general or specific. They specify appropriate treatment protocols based on scientific evidence, and collaboration between medical and/or psychological professionals involved in the treatment of a given in oncology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies, Biogen Idec transforms scientific discoveries into advances in human healthcare. For product labeling, press releases and additional information about the company, please visit www.biogenidec.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion